NIAID investigational vaccine protects cattle from RSV, provides model for developing an effective human RSV vaccine
by Press Release from Outbreak News Today on (#2FK33)
A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV) infection, according to research published online in npj Vaccines on March 8. The research was conducted by a team of experts at NIAID, the Pirbright ["]
The post NIAID investigational vaccine protects cattle from RSV, provides model for developing an effective human RSV vaccine appeared first on Outbreak News Today.